// App-Quantinova.ai

MON-048 : A new report of glomerulonephritis associated with the use of Talimogene laherparepvec immunotherapy.

Researchers

Presenter

  • R. Scott

Principal Investigators

  • S. Muller

  • P. Boddana

  • A. SINGH

Medical Centers

  • University of Bristol, Bristol Eye Hospital, Bristol, United Kingdom

  • Gloucestershire Hospitals NHS Trust, Gloucester, United Kingdom

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Urology

  • Infectious Diseases (ID)

  • Nephrology

Disease

  • Glomerulonephritis

Biomarkers

  • N/A

Drug/Treatment

  • Imlygic

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved